Literature DB >> 20022534

Socioeconomic impact of ankylosing spondylitis in Tunisia.

Mohamed Younes1, Anis Jalled, Zohra Aydi, Saoussen Zrour, Wided Korbaa, Zohra Ben Salah, Mondher Letaief, Ismail Bejia, Mongi Touzi, Naceur Bergaoui.   

Abstract

OBJECTIVE: Ankylosing spondylitis (AS) is the second most common chronic inflammatory joint disease after rheumatoid arthritis and causes substantial functional impairment, two features that generate a heavy socioeconomic burden. Here, our objective was to assess the socioeconomic impact of AS and to identify factors associated with higher costs. PATIENTS AND METHODS: We retrospectively reviewed the medical charts of 50 patients with AS seen at the Monastir Public Health Service Hospital over the 6-month period from March to September 2006. The following were evaluated: direct costs of medical care; indirect costs related to work incapacity; and impact on marital life, offspring, social activities, and activities of daily living.
RESULTS: There were 42 men and eight women (male-to-female ratio, 5.25) with a mean age of 38.9+/-10.8 years (range, 19-60 years). The median mean direct cost of medical care for AS was 426.072 Tunisian Dinars (TND) (266.295 euro) per year, and the interquartile range (IQR) was 270.468 TND. Of the 34 patients who had paid employment, 12 (35%) were on sick leave. The mean indirect cost was 447.4+/-294.3 TND (279.625+/-183.937 euro) per patient per year. The median mean total cost was 873.472 TND (545,92 euro) per patient per year with an IQR of 292,324 TND. Factors associated with higher costs were the use of nonsteroidal anti-inflammatory drugs and higher values of the BASDAI and BASRI. Among married patients, 44.4% reported sexual problems, which correlated with the BASMI; and 37% reported a negative reaction on the part of the healthy spouse. Adverse effects on schooling and quality of life of the children were noted in 29.6% of cases. Among single patients, 30.4% felt their disease was responsible for their unmarried status. The disease adversely affected the ability to carry out many activities of daily living (grooming in 38% of cases, housework in 76%, shopping in 92%, sporting activities in 96%, socializing in 68%, and traveling in 80%). The patients usually reported receiving support from their family, which was physical in 74% of cases, financial in 52%, and psychological in 90%.
CONCLUSION: Our data indicate that AS generates a major socioeconomic burden. Most of the factors associated with higher costs were related to greater disease activity. Therefore, early appropriate treatment is crucial. Despite the many socioeconomic problems generated by AS, the patients remained connected to their social network thanks to support from their family and friends. Copyright 2009 Société française de rhumatologie. Published by Elsevier SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20022534     DOI: 10.1016/j.jbspin.2009.11.007

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  9 in total

1.  Cross-cultural adaptation and validation of the Portuguese version of "The assessment of knowledge in ankylosing spondylitis patients by a self-administered questionnaire".

Authors:  Sofia Manuela da Rocha Lopes; José Alberto Duarte; Cristina Teresa Torrão Carvalho Mesquita
Journal:  Rheumatol Int       Date:  2016-02-08       Impact factor: 2.631

Review 2.  Spondyloarthritis in North Africa: an update.

Authors:  Samy Slimani; Wafa Hamdi; Kawtar Nassar; Asgar Ali Kalla
Journal:  Clin Rheumatol       Date:  2021-02-09       Impact factor: 2.980

Review 3.  Economic considerations of the treatment of ankylosing spondylitis.

Authors:  John D Reveille; Antonio Ximenes; Michael M Ward
Journal:  Am J Med Sci       Date:  2012-05       Impact factor: 2.378

4.  The relationship between disease activity measured by the BASDAI and psychological status, stressful life events, and sleep quality in ankylosing spondylitis.

Authors:  Yutong Jiang; Mingcan Yang; Husheng Wu; Hui Song; Feng Zhan; Shengyun Liu; Guanmin Gao; Zhangsuo Liu; Zhaoxian Hu; Peigen He; Shengtao Zhang; Zaiying Hu; Zhiming Lin; Yanli Zhang; Yinong Li; Lingxun Shen; Anbing Huang; Zetao Liao; Shuangyan Cao; Yanlin Wei; Li Li; Qiuxia Li; Qing Lv; Jun Qi; Jianlin Huang; Tianwang Li; O Jin; Yunfeng Pan; J Gu
Journal:  Clin Rheumatol       Date:  2014-06-20       Impact factor: 2.980

5.  Reparative radiological changes of hip joint after TNF inhibitors in ankylosing spondylitis.

Authors:  Kaouther Maatallah; Ines Mahmoud; Safa Belghali; Kawther Ben Abdelghani; Olfa Saidane; Elyes Bouajina; Ahmad Laatar; Rawdha Tekaya; Leila Abdelmoula
Journal:  Caspian J Intern Med       Date:  2018

Review 6.  HLA B27 antigen in Middle Eastern and Arab countries: systematic review of the strength of association with axial spondyloarthritis and methodological gaps.

Authors:  Nelly Raymond Ziade
Journal:  BMC Musculoskelet Disord       Date:  2017-06-29       Impact factor: 2.362

7.  Affective temperament profile in ankylosing spondylitis patients using TEMPS-A.

Authors:  Tulay Yildirim; Dilek Solmaz; Murat Emul; Gurkan Akgol; Dilek Yalvac; Yuksel Ersoy
Journal:  J Phys Ther Sci       Date:  2017-03-22

8.  Real-world experiences of the diagnosis process in Korean patients with ankylosing spondylitis based on a self-report questionnaire.

Authors:  Jin-Wuk Hur; Kyung Min Ko; Kyung-Su Park; Seung-Jae Hong; Hyun-Sook Kim; Myeung-Su Lee
Journal:  J Int Med Res       Date:  2021-04       Impact factor: 1.671

9.  Economic evaluation of spondyloarthritis: economic impact of diagnostic delay in Italy.

Authors:  Francesco S Mennini; Raffaella Viti; Andrea Marcellusi; Paolo Sciattella; Ombretta Viapiana; Maurizio Rossini
Journal:  Clinicoecon Outcomes Res       Date:  2018-01-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.